Does RISANKIZUMAB-RZAA Cause Syncope? 168 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 168 reports of Syncope have been filed in association with RISANKIZUMAB-RZAA. This represents 0.3% of all adverse event reports for RISANKIZUMAB-RZAA.
168
Reports of Syncope with RISANKIZUMAB-RZAA
0.3%
of all RISANKIZUMAB-RZAA reports
2
Deaths
62
Hospitalizations
How Dangerous Is Syncope From RISANKIZUMAB-RZAA?
Of the 168 reports, 2 (1.2%) resulted in death, 62 (36.9%) required hospitalization, and 3 (1.8%) were considered life-threatening.
Is Syncope Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 168 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Syncope?
AMBRISENTAN (2,140)
TREPROSTINIL (1,908)
ADALIMUMAB (1,795)
FUROSEMIDE (1,431)
LENALIDOMIDE (1,280)
BISOPROLOL (1,279)
METOPROLOL (1,251)
AMLODIPINE (1,224)
ASPIRIN (1,193)
SACUBITRIL\VALSARTAN (1,163)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Syncope Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA